Treatment Advancements and Management Strategies in Bipolar Disorder to Mitigate Challenges to Patient Care

Program Description

Bipolar disorder (BD), a mental health illness that leads to significant shifts in an individual’s mood, energy, and ability to think clearly. BD affects approximately 5.7 million people in the United States. For many, pharmacologic and nonpharmacologic therapies are ineffective; as such, nonadherence to treatment is common in BD, as the management of bipolar disorder is complex and involves several treatment modalities. Pharmacists are integral members of the health care team and can help patients achieve therapeutic goals, promote the use of effective and safe drugs to enhance patients’ quality of life, and ensure prompt and accurate diagnosis of BD through the early identification of risk factors and symptoms. This activity will review current and emerging treatment options for BD, as well as guidelines for its management. Strategies to address the burden of disease for patients will also be discussed.

Target audience: Health System Pharmacist, Retail Pharmacist, Specialty Pharmacist

Type of activity: Application
Release date: January 25, 2023
Expiration date: March 25, 2023

Time to complete activity: 1.0 hours
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Explore current challenges and unmet needs in bipolar disorder (BD)
• Examine the current treatment guidelines for the management of BD
• Analyze advancements in current treatments for BD and the investigational therapies in development
• Identify pharmacists’ roles in the management of BD across practice settings, including patient counseling, treatment recommendations, and access to therapy

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number 0290-0000-22-603-L01-P. The activity is available for CE credit through March 25, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, MBA, CHCP; Michelle Carlson, PharmD; Lauren Assennata; Susan Pordon; Brianna Winters; and Chloe Taccetta.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms